Retinyl Palmitate Encyclopedia — Scientific Background

What Is Retinyl Palmitate?

Retinyl palmitate (CAS 79-81-2), also known as vitamin A palmitate, retinol palmitate, or all-trans-retinyl palmitate, is the hexadecanoate ester of all-trans-retinol, chemically characterized by the molecular formula C₃₆H₆₀O₂ and a molecular weight of 524.86 g/mol. It is a retinyl ester that is obtained by the formal condensation of the carboxy group of palmitic acid with the hydroxy group of all-trans-retinol. The compound occurs as a light yellow solid or yellow oily liquid that is insoluble in water but soluble in hydrocarbons, chlorinated hydrocarbons, ethers, fats, and oils.

Physiological Functions of Vitamin A Palmitate

Vitamin A is an essential fat-soluble micronutrient required for numerous physiological processes:

• Vision — Vitamin A is essential for the visual cycle, particularly for the formation of rhodopsin, the light-sensitive pigment in the retina. Vitamin A is included in eye health formulations due to its role in maintaining vision, especially rhodopsin production in the retina.

• Gene Expression Regulation — Retinyl palmitate binds to and activates retinoid receptors, thereby inducing cell differentiation and decreasing cell proliferation. This agent also inhibits carcinogen-induced neoplastic transformation, induces apoptosis in some cancer cell types, and exhibits immunomodulatory properties.

• Immune Function — Vitamin A supports the normal development and function of immune cells, including T lymphocytes and neutrophils.

• Skin Health — In the skin, retinyl palmitate is converted to retinol and then to retinoic acid, which can promote cell turnover and collagen production. It is used in cosmetic products to treat various skin disorders such as acne, skin aging, wrinkles, and dark spots, and also protects against psoriasis.

• Cellular Differentiation — As the most common form of vitamin A taken for dietary supplementation, retinyl palmitate binds to and activates retinoid receptors, regulating gene expression related to cellular differentiation.

Mechanisms of Action

Retinoid Receptor Binding and Gene Expression

Retinyl palmitate is a naturally occurring phenyl analogue of retinol (vitamin A) with potential antineoplastic and chemopreventive activities. As the most common form of vitamin A taken for dietary supplementation, retinyl palmitate binds to and activates retinoid receptors, thereby inducing cell differentiation and decreasing cell proliferation. Retinoic acid, the active metabolite of vitamin A, acts as a ligand for nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs), regulating the transcription of numerous target genes involved in cellular differentiation, proliferation, and apoptosis.

Visual Cycle

Vitamin A is essential for the visual cycle. Retinal, the aldehyde form of vitamin A, combines with opsin to form rhodopsin, the light-sensitive pigment in rod cells. When light strikes rhodopsin, the retinal undergoes isomerization from 11-cis to all-trans, triggering a signal cascade that results in visual perception.

Antioxidant Activity

Retinyl palmitate has a role as an antioxidant and a human xenobiotic metabolite. It protects cellular membranes from oxidative damage and supports the body's antioxidant defense systems.

Skin Turnover and Collagen Production

In the skin, retinyl palmitate is converted to retinol and then to retinoic acid, which can promote cell turnover and collagen production. However, it is less potent than prescription retinoids like tretinoin.

The Bioavailability Challenge

Despite its essential physiological functions, native retinyl palmitate presents significant formulation challenges. The compound is highly susceptible to oxidative degradation and is sensitive to air, heat, and light. Its hydrophobic nature makes administration difficult by either intravenous or oral routes, requiring the utilization of oily formulations or surfactant-containing aqueous solutions. The therapeutic use of retinoids is further limited by many adverse effects, including strong toxicity (hypervitaminosis), poor chemical stability, and long-lasting teratogenicity.

These limitations have driven the development of advanced delivery systems, including liposomes, nanoemulsions, and solid lipid nanoparticles. Among these, liposomal encapsulation has emerged as one of the most effective strategies for enhancing retinyl palmitate stability, bioavailability, and safety.

Liposomal vitamin A Palmitate

Liposomal encapsulation of retinyl palmitate provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the retinyl palmitate molecule, forming a protective shell that enhances stability, reduces toxicity, and facilitates cellular uptake. This delivery system:

• Achieves particle sizes of 76–115 nm with monomodular distribution

• Increases zeta potential from −29 to −58 mV for superior electrostatic stability

• Reduces blood viscosity and causes less red blood cell lysis than free retinoid compounds

• Enhances the dispersion and stability of vitamin A, significantly improving dissolution rate and bioavailability

• Can be formulated to be 100% water-soluble and 100% oil-soluble (amphiphilic)

Liposome-encapsulated vitamin A compounds exhibit greater stability and diminished toxicity compared to free forms. Absorption and fluorescence studies show that retinol palmitate intercalated in phosphatidylcholine liposomes binds to the lipid bilayer, which protects it from oxidative degradation and environmental stressors. The delivery of liposome-incorporated retinoids to the blood reduces blood viscosity and causes less lysis of red blood cells than retinoid compounds not complexed in liposomes.

Clinical Evidence

Stability and Bioavailability

Retinyl palmitate-loaded nanoliposomes were prepared and characterized for particle size, zeta potential, encapsulation efficiency, and stability. The particle size was in the range of 76–115 nm with monomodular distribution. Incorporation of cholesterol and vitamin A palmitate into the liposome structure increased the zeta potential from −29 to −58 mV, significantly improving electrostatic stability. Nanoliposomal vitamin A palmitate greatly improves the dispersion and stability of vitamin A, significantly enhancing the dissolution rate and bioavailability of bioactive substances.

Food Fortification

Retinyl palmitate is widely used for fortifying fatty foods such as margarine, spreads, oils, milk, and dairy products. Quantities of 3–9 mg (10,000–30,000 IU) of vitamin A, calculated as retinol, are usually added per kg of margarine. For edible oil fortification, recommendations range from about 30,000 to 100,000 IU/kg (9–30 mg RE/kg). Large-scale food fortification can bring measurable improvements in vitamin A-dependent serum retinol concentrations and health status, particularly in children.

Pharmaceutical Applications

Retinyl palmitate is used in pharmaceutical applications, including in eye health formulations due to vitamin A's role in maintaining vision, and in treatments for certain skin disorders when combined with other agents. Both EU Drug Master File and US Drug Master File are available for pharmaceutical-grade vitamin A palmitate. The product is particularly suitable for manufacturing aqueous solutions using solubilizing agents such as Cremophor® EL or Cremophor® RH 40 for oral administration.

Cosmetic Applications

Retinyl palmitate is used in anti-aging creams, moisturizers, and sunscreen formulations. In the skin, it is converted to retinol and then to retinoic acid, which can promote cell turnover and collagen production. Clinical trials have evaluated retinyl palmitate-loaded ethosomes for the treatment of acne vulgaris, demonstrating that encapsulation of retinoids in vesicular carriers like liposomes and ethosomes can significantly improve their effects for acne treatment compared to commercial formulations and provide better tolerability of irritating retinoid.

Safety and Regulatory

Retinyl palmitate has a well-established safety profile when used appropriately. However, vitamin A is a fat-soluble vitamin, and excess intake can lead to hypervitaminosis A, causing symptoms like dizziness, nausea, headaches, and liver damage. Not recommended in high doses during pregnancy, as it may cause birth defects. The Tolerable Upper Intake Level (UL) for preformed vitamin A is 3,000 μg RAE/day (10,000 IU) for adults to prevent teratogenic effects and liver damage. Studies indicate that levels of Vitamin A in excess of 1,200 mcg daily can increase the incidence of birth defects or other reproductive harm.

Regulatory status varies by region:

• United States — Retinyl palmitate is regulated as a dietary supplement ingredient and food additive. It is Generally Recognized As Safe (GRAS) for use in food and dietary supplements. It is listed in the FDA Substances Added to Food database with CAS Registry No. 79-81-2.

• European Union — Retinyl palmitate complies with the current "Vitamin A concentrate (oily form), synthetic" Ph.Eur. monograph. It is authorized for use in food supplements and food fortification in EU member states.

• Global Standards — Retinyl palmitate is monographed in the USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. USP Vitamin A RS is retinyl acetate, and one USP Vitamin A Unit = 0.3 μg of all-trans-retinol or 0.55 μg of all-trans-retinyl palmitate.

Precautions: Pregnant or lactating women and children should consult a healthcare professional before use. Individuals taking anticoagulant medications or with liver conditions should consult a healthcare professional before supplementation. Vitamin A palmitate should not be used in high doses during pregnancy due to the risk of birth defects.

Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

109$/KG

89$/KG